Alert

BETR Already Up 92.3% in 7 Trading Days!

On the afternoon of December 18th, Psychstocks announced BetterLife Pharma (CSE: BETR) at $1.17 per share as its #1 favorite Psychstock for 2021. BETR closed today at its high of day of $2.25 per share. BETR has already gained by 92.3% in only seven trading days!

Read more
Alert

Our New #1 Psychstock for 2021

Our new #1 favorite Psychstock for 2021 is Betterlife Pharma (CSE: BETR) or BETRF on the U.S. OTCQB. BETR is currently trading for $1.17 per share.

Read more
Alert

CMPS Hits Record High, RVV Breaking Out!

Psychedelics industry bellwether Compass Pathways (CMPS) gained $6.62 or 16.21% today to finish at a new all-time high closing price of $47.45 per share! We consider Revive Therapeutics (CSE: RVV) to be the #1 highest quality small-cap psychedelic biotech play.

Read more
Alert

NUMI Hit $0.53 Up 86% in One Month

Yesterday morning, NUMI hit a high of $0.53 per share for a gain of 85.96% from our breakout point alert exactly one month ago on the morning of September 28th at $0.285 per share.

Read more
Alert

CMPS Featured on CNBC

Compass Pathways (CMPS) was featured on CNBC today, causing the stock to gain by $4.19 or 12.25% to close at $38.39 per share. Here is a video of the segment.

Read more
Alert

Psychstocks New #1 Pick: RVV

Psychstocks is extremely excited to announce its new #1 favorite psilocybin biotechnology stock suggestion: Revive Therapeutics (CSE: RVV). Revive also has a U.S. OTC symbol: RVVTF.

Read more
Alert

CMPS Hits New Record High, then Declines Due to Huge Gap Left in Chart

Following the release of Citron Research’s bullish report on Compass Pathways (CMPS), the stock gained as much as 28.44% to reach a new record high of $47.29 per share, but only finished the day up by 8.91% to $40.10 per share. We believe Andrew Left made a mistake by releasing his report before the open of trading.

Read more